PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Jacques Descotes Featured Speaker at Immunotoxicity Conference San Diego, California - Jacques Descotes to Speak at Immunotoxicity conference Jan 31 每 Feb 1, 2013 in San Diego, CA - GTCbio.com
Jacques Descotes Featured Speaker at Immunotoxicity Conference San Diego, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2012/10/18 - Jacques Descotes to Speak at Immunotoxicity conference Jan 31 每 Feb 1, 2013 in San Diego, CA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Jacques Descotes Professor and Head at the Poison Center and Pharmacovigilance Department at Lyon University General Hospitals, Lyon, France will give a feature presentation "Immunotoxicity evaluation: from standard toxicity studies to first-in-man clinical trials" at the Inaugural Immunogenicity and Immunotoxicity conference (Jan 31 - Feb 1, 2013 in San Diego, CA)

As recommended by the ICH S8 guideline, nonclinical Immunotoxicity evaluation should be incorporated into standard drug development to allow for a weight-of-evidence decision making approach prior to phase III clinical trials at the latest. Clinical signs, changes in standard hematology and clinical chemistry, and histology of lymphoid organs in repeat-dose toxicity studies are critical findings to be considered. Of concern is the finding that some drug candidates without an identified cause for concern significantly impaired immune function. Selected relevant immune function assays depend on whether the drug candidate is intended to modulate, or unexpectedly found to alter immune responses. The collected data should serve the purpose of risk assessment. Currently, a major gap is the lack of relevant translational findings to extrapolate animal data to first-in-man clinical trials and beyond. Dr. Descotes presentation will focus on those immune function measurements beyond TDAR assays, which could be incorporated into long-term repeat-dose toxicity studies to serve as a rationale for immunological monitoring during clinical trials of drug candidates.

Dr. Descotes has been active in clinical and nonclinical research on Immunotoxicology and regulatory safety evaluation for the past 30 years. He is the author of 13 books, 75 chapters from multi-authored books, 234 original scientific papers, 73 review papers, 434 oral presentations and posters. Dr Descotes has been a fellow of the US Academy of Toxicological Sciences since 2001. He was the recipient of the 2002 Eurotox Gerhard Zbinden Memorial Annual Award and 2010 (US) Society of Toxicology's Jeff Vos Career Achievement Award in Immunotoxicology.

In addition to Dr. Descotes featured presentation, Steve Swanson from Amgen will also present and the keynote address will be given by Anne De Groot from EpiVax.

The Inaugural Immunogenicity and Immunotoxicity conference will bring together a mix of academic and industry experts from leading affiliations (such as MedImmune, Roche, Ambryx, Aegis Therapeutics, Antitope, Epiontis, Amgen, EpiVax, Ablynx, Eleven Biotherapeutics, Bayer HealthCare and more) to cover many current and relevant aspects of Immunogenicity and Immunotoxicity.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Jacques Descotes Featured Speaker at Immunotoxicity Conference San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 Internet of Things for the Pyxis ES System
Greenphire Named to Deloitte 2016 Technology Fast 500
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Math Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere Radioembolisation Therapy
FDA Approves Genentechs Lucentis (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentechs Lucentis (Ranibizumab Injection) Supplemental Biologics License Application
Genentechs TECENTRIQ (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)